ResearchImmune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream1 Dermatology Office, Loma Linda University Medical Center, Loma Linda, California, USA 2 Pharmacology, 3M Pharmaceuticals, St Paul, Minnesota, USA 3 Medical & Scientific Affairs, 3M Pharmaceuticals, St Paul, Minnesota, USA
Journal of Translational Medicine 2007, 5:7doi:10.1186/1479-5876-5-7
Additional filesAdditional file 1: Imiquimod regulated genes. This file summarizes fold change in expression for 530 imiquimod regulated genes before and after treatment with imiquimod. Genes were selected on the basis of an ANOVA analysis comparing pre-treatment AK expression values to expression values during imiquimod treatment or 4-weeks after treatment with imiquimod, with P-values < 0.05 Format: DOC Size: 1022KB Download file This file can be viewed with: Microsoft Word Viewer Additional file 2: Comparison of differential expression as measured by Affymetrix gene array and real time RT-PCR. This file summarizes a comparison of differential gene expression as measured by Affymetrix gene chip analysis and real time RT-PCR using low density TaqMan arrays. Expression changes for several toll-like receptors and other selected genes before and after treatment with imiquimod are reported. Format: DOC Size: 80KB Download file This file can be viewed with: Microsoft Word Viewer Additional file 3: Imiquimod-induced genes with immune response gene ontology category and/or known to be IFNα/β-inducible. This file reports on expression changes before and after treatment with imiquimod, for selected genes with gene ontology category of immune response and (or) are know to be inducible by type 1 interferons. Format: DOC Size: 399KB Download file This file can be viewed with: Microsoft Word Viewer |





on Google Scholar









author email
corresponding author email